Athenex (ATNX) and Almirall Announces Pact for Treatment of Actinic Keratosis; Athenex will Receive Up-front Fee and Near-term Payments of up to $55 Million
Tweet Send to a Friend
Almirall, S.A (ALM), a global skin-health focused pharmaceutical company, today announced an agreement with Athenex, Inc. (Nasdaq: ATNX), a global ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
